Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Director departure
Quarterly results
Consulting agrmnt
Notes underwriting agrmnt

Ocata Therapeutics, Inc. (OCAT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2016 SC 13G/A ALPINE ASSOCIATES MANAGEMENT INC. reports a 5% stake in Ocata Therapeutics, Inc.
02/12/2016 SC 13G ALPINE ASSOCIATES MANAGEMENT INC. reports a 5.7% stake in Ocata Therapeutics, Inc.
02/12/2016 EFFECT Form EFFECT - Notice of Effectiveness
02/12/2016 EFFECT Form EFFECT - Notice of Effectiveness
02/12/2016 EFFECT Form EFFECT - Notice of Effectiveness
02/12/2016 EFFECT Form EFFECT - Notice of Effectiveness
02/12/2016 EFFECT Form EFFECT - Notice of Effectiveness
02/12/2016 EFFECT Form EFFECT - Notice of Effectiveness
02/11/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/11/2016 4 Myles Edward H (COO & CFO) has filed a Form 4 on Ocata Therapeutics, Inc.
Txns: Unknown transaction of 56,000 shares @ $8.5, valued at $476k
Disposed/sold 140,000 options to buy @ $7.78, valued at $1.1M
Disposed/sold 112,000 options to buy @ $8.49, valued at $950.9k
02/11/2016 4 PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
02/11/2016 4 LEVY BRIAN (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
02/11/2016 4 Jooste H Le Roux (SVP of Bus Development & CCO) has filed a Form 4 on Ocata Therapeutics, Inc.
Txns: Unknown transaction of 25,000 shares @ $8.5, valued at $212.5k
Disposed/sold 75,000 options to buy @ $6.32, valued at $474k
02/11/2016 4 SHAPIRO ALAN C (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
02/11/2016 4 Anglade Eddy (Chief Medical Officer) has filed a Form 4 on Ocata Therapeutics, Inc.
Txns: Unknown transaction of 56,000 shares @ $8.5, valued at $476k
Disposed/sold 100,000 options to buy @ $8.99, valued at $899k
Disposed/sold 112,000 options to buy @ $8.49, valued at $950.9k
Unknown transaction of 56,000 shares @ $8.5, valued at $476k
Disposed/sold 100,000 options to buy @ $8.99, valued at $899k
Disposed/sold 112,000 options to buy @ $8.49, valued at $950.9k
02/11/2016 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
Txns: Unknown transaction of 31,000 shares @ $8.5, valued at $263.5k
Disposed/sold 3,621 options to buy @ $8, valued at $29k
Disposed/sold 5,000 options to buy @ $5.79, valued at $29k
Disposed/sold 1,250 options to buy @ $6, valued at $7.5k
Disposed/sold 10,000 options to buy @ $6.17, valued at $61.7k
Disposed/sold 100,000 options to buy @ $7.94, valued at $794k
Disposed/sold 10,000 options to buy @ $6.39, valued at $63.9k
Disposed/sold 5,000 options to buy @ $8.36, valued at $41.8k
Unknown transaction of 31,000 shares @ $8.5, valued at $263.5k
Disposed/sold 3,621 options to buy @ $8, valued at $29k
Disposed/sold 5,000 options to buy @ $5.79, valued at $29k
02/11/2016 4 LOSHITZER ZOHAR (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
02/11/2016 4 LANGER ROBERT (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
02/11/2016 4 Wotton Paul K (President and CEO) has filed a Form 4 on Ocata Therapeutics, Inc.
Txns: Unknown transaction of 277,500 shares @ $8.5, valued at $2.4M
Disposed/sold 300,000 options to buy @ $6.55, valued at $2M
Unknown transaction of 277,500 shares @ $8.5, valued at $2.4M
Disposed/sold 300,000 options to buy @ $6.55, valued at $2M
02/11/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/10/2016 8-K Quarterly results
02/10/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
02/10/2016 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
01/04/2016 4 LANGER ROBERT (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
01/04/2016 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
Txns: Granted 2,500 shares @ $0
Granted 10,000 options to buy @ $8.36, valued at $83.6k
Granted 2,500 shares @ $0
Granted 10,000 options to buy @ $8.36, valued at $83.6k
01/04/2016 4 LEVY BRIAN (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
01/04/2016 4 LOSHITZER ZOHAR (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
01/04/2016 4 PERRY GREGORY D (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
01/04/2016 4 SHAPIRO ALAN C (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
12/18/2015 8-K Form 8-K - Current report
11/10/2015 4 Lanza Robert (Chief Scientific Officer) has filed a Form 4 on Ocata Therapeutics, Inc.
11/10/2015 8-K Form 8-K - Current report
11/09/2015 10-Q Quarterly Report for the period ended September 30, 2015
10/01/2015 4 LEVY BRIAN (Director) has filed a Form 4 on Ocata Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy